Skip to content

Startup & venture capital news

AdipoSeeds secures strategic backing for platelet therapies

Toho Holdings and Kohjin Bio invest in the Tokyo biotechnology company

By /

LinkedInX
AdipoSeeds: AdipoSeeds secures strategic backing for platelet therapies
AdipoSeeds official management page; photographer not stated

AdipoSeeds announced an equity financing on 16 October 2026 involving Toho Holdings and Kohjin Bio. The amount and lead investor were not stated. The Tokyo company develops platelet based regenerative products and services supporting platelet rich plasma treatments. Founded in July 2016 around research by Keio University's Yumiko Matsubara and colleagues, it is developing platelet like cells derived from human adipose tissue. Proceeds will support preparations for Japanese clinical development and expansion of its plasma processing business. The strategic relationships also cover potential distribution infrastructure and manufacturing support. The announcement describes development plans, not regulatory approval or proven therapeutic efficacy.

Keep reading

More Funding

All stories